Smith Group Asset Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Smith Group Asset Management’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-63,049	Closed	-$265K	–	354
2020 Q4	$265K	Sell	63,049 -120	-0.2%	-$462	0.02%	166
2020 Q3	$236K	Sell	63,169 -70	-0.1%	-$298	0.01%	163
2020 Q2	$276K	Sell	63,239 -780	-1%	-$3.5K	0.02%	153
2020 Q1	$243K	Sell	64,019 -3,100	-5%	-$15.2K	0.01%	152
2019 Q4	$424K	Buy	+67,119	New	+$395K	0.02%	158

Other funds holding BDSI

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Smith Group Asset Management's BDSI Position: Q1 2021 in Review

Smith Group Asset Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2021, closing a stake of 63,049 shares — an estimated $265K sold.

Smith Group Asset Management first reported a position in BDSI in Q4 2019 and held it in 5 quarters. The position peaked at $424K in Q4 2019. 151 funds tracked by Wall St. Rank hold BDSI as of Q1 2021.

Smith Group Asset Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2021 after selling out during the quarter.
Smith Group Asset Management sold 63,049 BioDelivery Sciences International, Inc. shares in Q1 2021, an estimated $265K.
Smith Group Asset Management first reported a position in BioDelivery Sciences International, Inc. in Q4 2019 and held it in 5 quarters.
Smith Group Asset Management's BioDelivery Sciences International, Inc. position peaked at $424K in Q4 2019.
151 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2021.

Based on Smith Group Asset Management's 13F filing for Q1 2021, filed 7 May 2021.